Toluene

Toluene

SCHEMBL282478

Cc1ccccc1.F.F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL28249699 1.00 ACHE (0.92)
Toluene SCHEMBL11878868 1.00
Toluene SCHEMBL27965308 1.00 ACHE (0.92)
Toluene SCHEMBL6746582 1.00 ACHE (0.92)
Toluene SCHEMBL4386213 1.00 ACHE (0.92)
Toluene SCHEMBL28081861 1.00 ACHE (0.92)
Toluene SCHEMBL14954115 0.96 ACHE (0.85)
Toluene SCHEMBL27392244 0.96 ACHE (0.85)
Toluene SCHEMBL14954460 0.96 ACHE (0.85)
Toluene SCHEMBL29111169 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108358767-B Pentabenzyl benzene-containing difluoride monomer, preparation method and application thereof in polyaryletherketone functional film 吉林大学 2021-06-04 CN disclosed
CN-108358767-B Pentabenzyl benzene-containing difluoride monomer, preparation method and application thereof in polyaryletherketone functional film 吉林大学 2021-06-04 CN disclosed
US-10925885-B2 Thyromimetics for the treatment of fatty liver diseases METABASIS THERAPEUTICS, INC. (US) 2021-02-23 US disclosed
US-20190083515-A1 THYROMIMETICS FOR THE TREATMENT OF FATTY LIVER DISEASES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2019-03-21 US disclosed
US-10130643-B2 Thyromimetics for the treatment of fatty liver diseases METABASIS THERAPEUTICS, INC. (US) 2018-11-20 US disclosed
US-20170112864-A1 Thyromimetics for the Treatment of Fatty Liver Diseases METABASIS THERAPEUTICS, INC. (US) 2017-04-27 US disclosed
EP-1689383-B1 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS INC (US) 2012-10-31 EP disclosed
EP-2428516-A1 Novel phosphorus-containing thyromimetics Metabasis Therapeutics, Inc. (US) 2012-03-14 EP disclosed
US-7829552-B2 Phosphorus-containing thyromimetics METABASIS THERAPEUTICS, INC. (US) 2010-11-09 US disclosed
US-20100081634-A1 Novel Phosphorus-Containing Thyromimetics METABASIS THERAPEUTICS, INC. (US) 2010-04-01 US disclosed
CN-1882327-A Novel phosphorus-containing thyromimetics METABASIS THERAPEUTICS INC (US) 2006-12-20 CN disclosed
WO-2006128058-A2 THYROMIMETICS FOR THE TREATMENT OF FATTY LIVER DISEASES METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
WO-2006128056-A2 NOVEL PHOSPHINIC ACID-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
WO-2006128055-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
EP-1689383-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2006-08-16 EP disclosed
US-20060046980-A1 Novel phosphorus-containing thyromimetics METABASIS THERAPEUTICS, INC. 2006-03-02 US disclosed
WO-2005051298-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2005-06-09 WO disclosed
WO-1994012593-A1 CATALYTIC AROMATIC SATURATION IN THE PRESENCE OF HALIDE UNION OIL COMPANY OF CALIFORNIA (US) 1994-06-09 WO disclosed
US-5290429-A Hydrogenation of aromatic compounds, nickel, tungsten, phosphorous, fluorine containing catalyst UNION OIL COMPANY OF CALIFORNIA (US) 1994-03-01 US disclosed
US-4582592-A EXTENDING EFFECTIVE LIFE OF ALUMINA-SUPPORTED CATALYST CHEVRON RESEARCH COMPANY (US) 1986-04-15 US disclosed